These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 33532180)

  • 1. Recent advances in drug delivery systems for targeting cancer stem cells.
    Duan H; Liu Y; Gao Z; Huang W
    Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration.
    Ju Y; Hu Y; Yang P; Xie X; Fang B
    Mater Today Bio; 2023 Feb; 18():100522. PubMed ID: 36593913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer.
    Sarkar R; Biswas S; Ghosh R; Samanta P; Pakhira S; Mondal M; Dutta Gupta Y; Bhandary S; Saha P; Bhowmik A; Hajra S
    J Nanobiotechnology; 2024 May; 22(1):285. PubMed ID: 38796426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
    Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
    Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
    Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
    J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery strategies of amphotericin B for invasive fungal infections.
    Wang X; Mohammad IS; Fan L; Zhao Z; Nurunnabi M; Sallam MA; Wu J; Chen Z; Yin L; He W
    Acta Pharm Sin B; 2021 Aug; 11(8):2585-2604. PubMed ID: 34522599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology underlying the robustness of cancer stem cells.
    Yoshida GJ; Saya H
    Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in nanomedicines for the treatment of ischemic stroke.
    Li C; Sun T; Jiang C
    Acta Pharm Sin B; 2021 Jul; 11(7):1767-1788. PubMed ID: 34386320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.
    Qiao Q; Liu X; Yang T; Cui K; Kong L; Yang C; Zhang Z
    Acta Pharm Sin B; 2021 Oct; 11(10):3060-3091. PubMed ID: 33977080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.